Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study: Delays filling biologic prescriptions have consequences

Publish date:: March 24, 2020

Key clinical point: Long waits for biologics leave severe allergy patients prone to attacks.

Major finding: Average wait for new prescriptions was 44 days.

Study details: Single-center review of new prescriptions of monoclonal antibodies written from March 2014 to August 2019 of 80 patients.

Disclosures: Dr. Ishmael has no relevant financial relationships to disclose.

Citation:

Ishmael F et al. AAAAI 2020. Session 3609, Presentation 558.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Asthma

More data on impact of corticosteroids on COVID-19 mortality in patients with COPD,

Omalizumab shown to improve rhinosinusitis with polyps,

Ragweed SLIT tablets improve asthma outcome scores in patients with allergic rhinoconjunctivitis,

Peanut OIT-induced eosinophilia may eventually resolve,

Gene-targeting therapy shown to reduce mastocytosis symptoms,